THCT · As filed with the SEC

THC Therapeutics cash flow statement, by quarter

The statement as THC Therapeutics presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONSOLIDATED STATEMENT OF CASH FLOWS · USD

USD	Q4 FY24^† 3 months ended Jul 31, 2024	Q3 FY24^† 3 months ended Apr 30, 2024	Q2 FY24^† 3 months ended Jan 31, 2024	Q1 FY24 3 months ended Oct 31, 2023
Cash Flows from Operating Activities
Net loss	(281,724)^†	104,622^†	(571,975)^†	(62,485)
Adjustments to reconcile net loss to net cash used by operating activities:
Loss (gain) on change in derivative liabilities	173,060^†	(502,657)^†	467,154^†	(12,113)
Interest Expense	—	—	0^†	0
Stock-Based Compensation Expense	0^†	222,000^†	0^†	0
Gain on settlement of debt	0^†	0^†	0^†	0
Depreciation Expense	351^†	344^†	351^†	351
Changes in operating assets and liabilities
Increase in inventory	0^†	0^†	0^†	0
Decrease in prepaid assets	0^†	0^†	0^†	970
Increase in accounts payable and accrued expenses	26,796^†	38,629^†	58,500^†	72,156
Change in Accounts Payable	80,703^†	0^†	842^†	852
Net cash used in operating activities	(814)^†	(137,062)^†	(45,128)^†	(269)
Net Cash from Investing Activities	—	—	0^†	0
Cash Flows provided by Financing Activities
Proceeds from Debt Issuance	0^†	85,480^†	236^†	269
Payments on related party advances	0^†	0^†	(527)^†	0
Stock Repurchases (Issuances)	0^†	0^†	—	—
Proceeds from Stock Issuance	0^†	48,920^†	—	—
Net cash provided by financing activities	0^†	134,400^†	48,629^†	269
Net increase in Cash	—	—	3,501^†	0
Net decrease in Cash	(814)^†	—	—	—
Beginning cash balance	849	3,511	10	10
Ending cash balance	35	849	3,511	10
Supplemental disclosure of cash flow information
Interest Expense	0^†	0^†	0^†	0
Cash paid for tax	—	—	—	0
Income Tax Expense	0^†	—	—	—
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Silver used to settle debt	0^†	0^†	—	—

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.